CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
6.79
10.19%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Veradigm Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 7.56
Open* 7.12
1-Year Change* -57.08%
Day's Range* 6.22 - 7.25
52 wk Range 8.68-18.81
Average Volume (10 days) 2.15M
Average Volume (3 months) 30.87M
Market Cap 989.89M
P/E Ratio 9.63
Shares Outstanding 109.26M
Revenue 837.19M
EPS 0.94
Dividend (Yield %) N/A
Beta 0.72
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 28, 2024 6.79 -0.14 -2.02% 6.93 7.30 6.18
Feb 27, 2024 7.56 0.68 9.88% 6.88 7.84 6.77
Feb 26, 2024 8.27 0.02 0.24% 8.25 8.51 8.20
Feb 23, 2024 8.24 0.00 0.00% 8.24 8.31 8.16
Feb 22, 2024 8.34 0.21 2.58% 8.13 8.41 8.02
Feb 21, 2024 8.25 -0.07 -0.84% 8.32 8.34 8.22
Feb 20, 2024 8.34 0.28 3.47% 8.06 8.47 8.05
Feb 16, 2024 8.23 -0.10 -1.20% 8.33 8.47 8.20
Feb 15, 2024 8.49 0.42 5.20% 8.07 8.51 8.06
Feb 14, 2024 8.02 -0.22 -2.67% 8.24 8.30 7.86
Feb 13, 2024 8.23 -0.22 -2.60% 8.45 8.60 8.19
Feb 12, 2024 8.60 0.15 1.78% 8.45 8.73 8.45
Feb 9, 2024 8.51 0.27 3.28% 8.24 8.57 8.24
Feb 8, 2024 8.48 0.13 1.56% 8.35 8.51 8.20
Feb 7, 2024 8.35 -0.51 -5.76% 8.86 8.88 8.33
Feb 6, 2024 8.93 -0.04 -0.45% 8.97 9.24 8.79
Feb 5, 2024 9.07 0.16 1.80% 8.91 9.25 8.86
Feb 2, 2024 8.98 -0.11 -1.21% 9.09 9.17 8.96
Feb 1, 2024 9.16 0.07 0.77% 9.09 9.22 9.08
Jan 31, 2024 9.10 -0.25 -2.67% 9.35 9.46 9.09

Allscripts Events

Time (UTC) Country Event
Monday, March 4, 2024

Time (UTC)

14:50

Country

US

Event

Veradigm Inc at TD Cowen Health Care Conference
Veradigm Inc at TD Cowen Health Care Conference

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 1503.04 1502.7 1632.61 1617.84 1497.71
Revenue 1503.04 1502.7 1632.61 1617.84 1497.71
Cost of Revenue, Total 883.472 937.005 1022.32 996.45 864.909
Gross Profit 619.565 565.695 610.287 621.391 632.799
Total Operating Expense 1417.47 1635.16 1732.95 1629.45 1650.51
Selling/General/Admin. Expenses, Total 313.814 389.941 400.808 432.849 400.688
Research & Development 193.671 206.061 245.443 258.736 202.282
Depreciation / Amortization 23.109 25.604 27.188 26.558 17.345
Unusual Expense (Income) 3.402 76.544 37.188 -85.139 165.29
Operating Income 85.569 -132.455 -100.34 -11.613 -152.806
Interest Income (Expense), Net Non-Operating -11.409 -16.91 -42.507 -50.655 -36.719
Other, Net 87.666 0.054 -138.904 0.069 -0.512
Net Income Before Taxes 161.826 -149.311 -281.751 -62.199 -190.037
Net Income After Taxes 133.975 -132.619 -241.383 -43.216 -169.179
Minority Interest 0 0 0.424 4.527 1.566
Net Income Before Extra. Items 133.975 -132.619 -240.959 -38.689 -167.613
Total Extraordinary Items 0.463 833.026 58.781 402.429 -28.846
Net Income 134.438 700.407 -182.178 363.74 -196.459
Income Available to Common Excl. Extra. Items 133.975 -132.619 -240.959 -38.689 -167.613
Income Available to Common Incl. Extra. Items 134.438 700.407 -182.178 363.74 -196.459
Diluted Net Income 134.438 700.407 -182.178 363.74 -196.459
Diluted Weighted Average Shares 138.658 159.281 166.306 176.038 180.83
Diluted EPS Excluding Extraordinary Items 0.96623 -0.83261 -1.44889 -0.21978 -0.92691
Diluted Normalized EPS 0.98654 -0.52025 -1.30354 -0.53414 -0.33277
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Total revenue 151.922 150.898 142.672 391.699 144.668
Revenue 151.922 150.898 142.672 391.699 144.668
Cost of Revenue, Total 68.486 71.416 69.191 222.706 75.028
Gross Profit 83.436 79.482 73.481 168.993 69.64
Total Operating Expense 126.921 156.254 136.1 350.312 117.821
Selling/General/Admin. Expenses, Total 32.518 59.647 41.318 74.222 27.392
Research & Development 23.681 22.75 23.42 47.739 21.042
Depreciation / Amortization 2.236 2.241 2.171 5.643 2.363
Operating Income 25.001 -5.356 6.572 41.387 26.847
Interest Income (Expense), Net Non-Operating -1.863 -2.094 -2.534 -1.379 -3.874
Other, Net 1.655 2.133 0.012 65.172 4.493
Net Income Before Taxes 24.793 -5.317 4.05 105.18 27.466
Net Income After Taxes 10.925 3.262 18.471 87.283 20.276
Net Income Before Extra. Items 10.925 3.262 18.471 87.283 20.276
Total Extraordinary Items 3.603 -67.288 4.386 -0.008 -4.096
Net Income 14.528 -64.026 22.857 87.275 16.18
Income Available to Common Excl. Extra. Items 10.925 3.262 18.471 87.283 20.276
Income Available to Common Incl. Extra. Items 14.528 -64.026 22.857 87.275 16.18
Diluted Net Income 14.528 -64.026 22.857 87.275 16.18
Diluted Weighted Average Shares 110.206 114.251 138.685 128.389 123.892
Diluted EPS Excluding Extraordinary Items 0.09913 0.02855 0.13319 0.67983 0.16366
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.09913 0.02969 0.13319 0.67985 0.11597
Unusual Expense (Income) 0 0.2 0.002 -8.004
Minority Interest 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 1554.5 1153.22 841.262 858.965 857.11
Cash and Short Term Investments 132.517 531.104 129.668 174.243 119.47
Cash & Equivalents 132.517 531.104 129.668 174.243 119.47
Total Receivables, Net 235.051 479.493 555.733 531.715 492.56
Accounts Receivable - Trade, Net 235.051 454.072 555.733 531.715 492.56
Prepaid Expenses 60.511 136.264 147.99 142.193 105.319
Other Current Assets, Total 1126.42 6.361 7.871 10.814 139.761
Total Assets 2425.23 2917.62 3205.74 3181.48 4230.15
Property/Plant/Equipment, Total - Net 28.143 168.763 186.359 121.913 135.417
Property/Plant/Equipment, Total - Gross 492.736 506.71 401.116 380.694
Accumulated Depreciation, Total -323.973 -320.351 -279.203 -245.277
Goodwill, Net 506.607 974.729 1362.02 1373.74 1292.75
Intangibles, Net 224.378 479.804 618.071 640.741 630.418
Long Term Investments 12.26 10.744 11.332
Other Long Term Assets, Total 71.169 86.674 119.139 114.242 1314.46
Total Current Liabilities 597.988 934.777 1210.69 797.73 889.625
Accounts Payable 5.281 35.905 104.014 73.166 85.749
Accrued Expenses 91.706 203.456 326.855 179.777 146.677
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 364.547 21.055 28.789
Other Current Liabilities, Total 501.001 695.416 415.274 523.732 628.41
Total Liabilities 1017.09 1251.38 1920.55 1630.37 3109.27
Total Long Term Debt 350.062 167.587 551.049 648.307 909.072
Long Term Debt 350.062 167.587 551.004 647.539 906.725
Capital Lease Obligations 0.045 0.768 2.347
Deferred Income Tax 16.625 18.186 21.038 58.47 23.258
Minority Interest 0 29.314 470.725
Other Liabilities, Total 52.416 130.825 137.774 96.55 816.588
Total Equity 1408.14 1666.24 1285.19 1551.11 1120.88
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2.766 2.745 2.725 2.709 2.693
Additional Paid-In Capital 1962.39 1902.78 1907.35 1881.49 1781.06
Retained Earnings (Accumulated Deficit) 767.556 633.118 -49.336 132.842 -338.15
Treasury Stock - Common -1321.81 -870.558 -571.157 -460.543 -322.735
Unrealized Gain (Loss) -4.392 -5.584 -2.676
Other Equity, Total -2.765 -1.838 0 0.195 0.691
Total Liabilities & Shareholders’ Equity 2425.23 2917.62 3205.74 3181.48 4230.15
Total Common Shares Outstanding 116.114 139.942 162.475 171.224 180.831
Note Receivable - Long Term 28.174 43.682 67.559 71.879 0
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Total Current Assets 810.77 828.767 1540.68 1554.5 804.961
Cash and Short Term Investments 492.597 500.164 82.782 132.517 214.179
Cash & Equivalents 492.597 500.164 82.782 132.517 214.179
Total Receivables, Net 234.482 215.775 225.659 235.051 464.168
Accounts Receivable - Trade, Net 234.482 215.775 225.659 235.051 464.168
Prepaid Expenses 74.384 91.521 56.191 60.511 124.473
Other Current Assets, Total 9.307 21.307 1176.05 1126.42 2.141
Total Assets 1690.66 1714.22 2430.25 2425.23 2484.31
Property/Plant/Equipment, Total - Net 26.233 30.875 26.075 28.143 123.964
Goodwill, Net 523.927 524.149 520.187 506.607 974.427
Intangibles, Net 223.358 231.751 236.619 224.378 425.129
Note Receivable - Long Term 27.957 19.358 19.198 28.174 51.119
Other Long Term Assets, Total 66.361 67.737 75.63 71.169 104.706
Total Current Liabilities 253.091 256.328 646.855 597.988 566.94
Accounts Payable 12.609 18.014 15.548 5.281 21.801
Accrued Expenses 122.94 123.06 85.828 91.706 205.547
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 117.542 115.254 545.479 501.001 339.592
Total Liabilities 513.636 517.868 1077.15 1017.09 1065.72
Total Long Term Debt 200.326 199.895 377.059 350.062 373.187
Long Term Debt 200.326 199.895 377.059 350.062 373.187
Deferred Income Tax 8.082 10.861 0 16.625 16.494
Other Liabilities, Total 52.137 50.784 53.235 52.416 109.098
Total Equity 1177.02 1196.35 1353.11 1408.14 1418.59
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2.794 2.79 2.776 2.766 2.766
Additional Paid-In Capital 1923.56 1923.81 1922.03 1962.39 1952.1
Retained Earnings (Accumulated Deficit) 753.392 738.864 802.89 767.556 680.281
Treasury Stock - Common -1498.84 -1465.18 -1371.48 -1321.81 -1213.31
Other Equity, Total -3.886 -3.934 -3.102 -2.765 -3.242
Total Liabilities & Shareholders’ Equity 1690.66 1714.22 2430.25 2425.23 2484.31
Total Common Shares Outstanding 109.26 110.792 114.792 116.114 122.57
Long Term Investments 12.053 11.579 11.862 12.26
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 133.975 -132.619 -182.602 407.807 -154.175
Cash From Operating Activities -75.428 -106.715 46.254 67.891 247.911
Cash From Operating Activities 176.137 192.269 207.106 192.346 157.328
Deferred Taxes -2.099 -3.275 -37.97 4.144 -10.228
Non-Cash Items -359.954 -10.842 78.081 -476.32 197.24
Cash Taxes Paid 330.473 76.595 42.972 10.108 6.675
Cash Interest Paid 4.993 24.616 19.604 28.888 21.183
Changes in Working Capital -23.487 -152.248 -18.361 -60.086 57.746
Cash From Investing Activities -12.175 1615.19 -161.056 248.013 -412.972
Capital Expenditures -78.56 -105.018 -130.436 -144.617 -157
Other Investing Cash Flow Items, Total 66.385 1720.21 -30.62 392.63 -255.972
Cash From Financing Activities -258.866 -1109.76 67.343 -292.983 198.585
Financing Cash Flow Items -16.423 -10.402 -92.993 128.123 23.515
Issuance (Retirement) of Stock, Net -417.443 -334.863 -111.46 -137.645 -10.509
Issuance (Retirement) of Debt, Net 175 -764.494 271.796 -283.461 185.579
Foreign Exchange Effects -0.476 1.212 0.203 -0.624 0.86
Net Change in Cash -346.945 399.926 -47.256 22.297 34.384
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Net income/Starting Line 32.658 21.733 18.471 133.975 46.692
Cash From Operating Activities 95.767 67.626 69.261 -75.428 -140.472
Cash From Operating Activities 42.278 28.465 14.101 176.137 132.989
Deferred Taxes -2.978 -0.467 -17.042 -2.099 -1.65
Non-Cash Items -8.608 0.379 38.475 -359.954 -305.842
Changes in Working Capital 32.417 17.516 15.256 -23.487 -12.661
Cash From Investing Activities 603.719 612.973 -44.199 -12.175 -54.873
Capital Expenditures -28.083 -19.91 -9.945 -78.56 -60.033
Other Investing Cash Flow Items, Total 631.802 632.883 -34.254 66.385 5.16
Cash From Financing Activities -387.374 -348.92 -62.966 -258.866 -125.32
Financing Cash Flow Items -32.678 -27.883 -13.287 -16.423 -16.367
Issuance (Retirement) of Stock, Net -177.031 -143.372 -49.679 -417.443 -308.953
Issuance (Retirement) of Debt, Net -177.665 -177.665 0 175 200
Foreign Exchange Effects -0.728 -0.728 -0.011 -0.476 -0.48
Net Change in Cash 311.384 330.951 -37.915 -346.945 -321.145
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 15.463 16894830 -376331 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 12.9805 14182422 82401 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 8.2693 9035018 -77938 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.6921 4034005 71466 2023-06-30 LOW
D. E. Shaw & Co., L.P. Hedge Fund 3.4932 3816655 280302 2023-06-30 MED
William Blair Investment Management, LLC Investment Advisor/Hedge Fund 3.4336 3751567 327836 2023-06-30 LOW
Fisher Investments Investment Advisor/Hedge Fund 2.5871 2826645 -102737 2023-06-30 LOW
Fuller & Thaler Asset Management Inc. Investment Advisor/Hedge Fund 2.3673 2586558 3244 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0632 2254299 67066 2023-06-30 LOW
Westfield Capital Management Company, L.P. Investment Advisor/Hedge Fund 2.0466 2236112 773424 2023-06-30 MED
Point72 Asset Management, L.P. Hedge Fund 1.7926 1958639 1944029 2023-06-30 HIGH
Charles Schwab Investment Management, Inc. Investment Advisor 1.5617 1706269 171083 2023-06-30 LOW
Two Sigma Investments, LP Hedge Fund 1.529 1670609 675616 2023-06-30 HIGH
Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 1.4756 1612241 -103315 2023-06-30 MED
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.3232 1445777 -371254 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.2672 1384495 -163861 2023-06-30 LOW
Goldman Sachs Asset Management, L.P. Investment Advisor 1.232 1346096 -464466 2023-06-30 LOW
RBC Global Asset Management (U.S.) Inc. Investment Advisor/Hedge Fund 1.1874 1297337 13850 2023-06-30 LOW
Fort Washington Investment Advisors, Inc. Investment Advisor 1.172 1280539 372410 2023-06-30 LOW
BofA Global Research (US) Research Firm 1.0636 1162101 -422238 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Allscripts Company profile

About Allscripts Healthcare Solutions Inc

Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The Company’s segments include the Hospitals and Large Physician Practices and the Veradigm. The Hospitals and Large Physician Practices reportable segment offers integrated clinical and financial management solutions, which primarily include (electronic health record) EHR-related software, related installation, support and maintenance, outsourcing and private cloud hosting. The Veradigm reportable segment offers payer and life sciences solutions, which are mainly targeted at payers, life sciences companies and other key healthcare stakeholders. The Veradigm also offers software applications for patient engagement and the sale of EHR software to single-specialty and small and mid-sized physician practices, including related clinical, financial, administrative and operational solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Allscripts Healthcare Solutions Inc revenues remained flat at $1.5B. Net income before extraordinary items totaled $134M vs. loss of $132.6M. Revenues reflect Data, Analytics and Care Coordination segment increase from $261.3M to $552.2M, Other international segment increase of 13% to $53.7M, Canada segment increase of 2% to $16M.

Equity composition

Common Stock $.01 Par, 03/11, 199M auth., 252,492,000 issd., less 61,308,000 shs. in Treas. @ $613K Insiders own 7.49%. IPO: 7/23/99, 7M shs @ $16 by Goldman, Sachs & Co. PO: 3/00, 2.4M shares (1,092,000 by the Co.) @ $73 by Goldman, Sachs. All Preferred stock converted into Common upon IPO. 8/10 Name chanhe from Allscripts-misys Healthcare Solutions

Industry: Medical Software & Technology Services

222 Merchandise Mart Plaza
Suite 2024
CHICAGO
ILLINOIS 60654
US

Income Statement

  • Annual
  • Quarterly

News

Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

18:44, 1 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

People also watch

BTC/USD

62,131.25 Price
-0.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+4.530% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,083.15 Price
+1.890% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0108%
Overnight fee time 22:00 (UTC)
Spread 0.50

US100

18,286.90 Price
+1.410% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading